Optimal design of pharmacokinetic studies

Basic & Clinical Pharmacology & Toxicology
Leon Aarons, Kayode Ogungbenro

Abstract

Experimental design is fundamental to successful scientific investigation. Poorly designed experiments lead to the loss of information, which is costly and potentially unethical. Experiments can be designed in an optimal fashion to maximize the amount of information they provide. Optimal design theory uses prior information about the model and parameter estimates to optimize a function of the Fisher information matrix to obtain the best combination of the design factors. In the case of population pharmacokinetic experiments, this involves the selection and a careful balance of a number of design factors, including the number and location of measurement times and the number of subjects to include in the study. It is expected that as the awareness about the benefits of this approach increases, more people will embrace it and ultimately will lead to more efficient population pharmacokinetic experiments and can also help to reduce both cost and time during drug development. This MiniReview provides an introduction to optimal design using examples taken from different pharmacokinetic experiments.

References

Mar 1, 1979·Computer Programs in Biomedicine·D Z D'Argenio, A Schumitzky
Jun 1, 1992·Journal of Pharmacokinetics and Biopharmaceutics·D B WhiteT H Grasela
Dec 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·D Z D'Argenio
Feb 1, 1995·Journal of Pharmacokinetics and Biopharmaceutics·Y Merlé, F Mentré
Sep 15, 1999·Journal of Pharmacokinetics and Biopharmaceutics·M TodA Mallet
May 5, 2001·Pharmaceutical Research·P I Lee
May 5, 2001·Pharmaceutical Research·S B DuffullL Aarons
Jun 29, 2002·Computer Methods and Programs in Biomedicine·Stephen B DuffullFrance Mentré
Nov 27, 2002·Journal of Pharmacokinetics and Pharmacodynamics·David J LunnDavid Spiegelhalter
Feb 8, 2003·Annals of Biomedical Engineering·Andrew C HookerPaolo Vicini
Oct 1, 1958·Journal of Chronic Diseases·C M FISHER
Sep 7, 2004·Journal of Pharmacokinetics and Pharmacodynamics·Ulrika WählbyE Niclas Jonsson
Sep 6, 2005·Computer Methods and Programs in Biomedicine·Kayode OgungbenroLeon Aarons
Nov 15, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Dongwoo KangDavide Verotta
Mar 22, 2006·Journal of Pharmacokinetics and Pharmacodynamics·Ivelina GueorguievaMalcolm Rowland
Apr 6, 2006·Journal of Biopharmaceutical Statistics·Kayode OgungbenroGordon Graham
Apr 6, 2006·The AAPS Journal·Andrew Hooker, Paolo Vicini
Feb 8, 2007·Journal of Pharmacokinetics and Pharmacodynamics·Kayode OgungbenroLeon Aarons
Mar 11, 2008·Journal of Biopharmaceutical Statistics·Kayode OgungbenroLeon Aarons
May 17, 2008·European Journal of Clinical Pharmacology·Kayode Ogungbenro, Leon Aarons
Jan 8, 2009·Journal of Biopharmaceutical Statistics·Kayode Ogungbenro, Leon Aarons
Jun 1, 1992·Trends in Ecology & Evolution·D Atkinson

❮ Previous
Next ❯

Citations

Jun 5, 2012·European Journal of Clinical Pharmacology·Surulivelrajan MallaysamyDevarakonda Ramakrishna
Dec 1, 2012·Journal of Pharmacokinetics and Pharmacodynamics·A TanejaO Della Pasqua
Dec 19, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Emma C MartinJames W T Yates
Dec 15, 2015·Expert Review of Clinical Pharmacology·Timothy M E DavisLaurens Manning
May 29, 2012·Expert Opinion on Drug Metabolism & Toxicology·Apexa BernardItalo Poggesi
Sep 13, 2013·Journal of Pharmaceutical Sciences·Mike DoddsMegan Gibbs
Apr 20, 2013·Zeitschrift für medizinische Physik·Gerhard GlattingMichael Lassmann
Jan 20, 2016·Clinical Pharmacology and Therapeutics·Diane R MouldRichard N Upton
Jan 5, 2014·Acta Anaesthesiologica Scandinavica·P VälitaloH Kokki
Jan 13, 2015·Paediatric Anaesthesia·Jessica K RobertsCatherine M T Sherwin
Dec 21, 2013·Archives of Disease in Childhood·Rick AdmiraalCatherijne A J Knibbe
Dec 20, 2013·Drug Metabolism and Pharmacokinetics·Min DongAlexander A Vinks
Jun 15, 2018·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Andrea L Goodnight, Sherry Cox
Sep 25, 2018·Journal of Clinical Pharmacology·Michael NeelyAndrea Edginton
Feb 24, 2015·Transplant Infectious Disease : an Official Journal of the Transplantation Society·S K HegazyN M Khalafallah
Feb 9, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Kate O'HaraJennifer J Schneider
Aug 18, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Jasbir SinghTomasz Grabowski
Oct 27, 2020·Journal of Clinical Pharmacology·Monia GuidiThierry Buclin
Nov 10, 2020·European Journal of Clinical Pharmacology·Anna Mueller-SchoellCharlotte Kloft
May 16, 2021·British Journal of Clinical Pharmacology·Ethel D WeldCatriona Waitt
Jan 28, 2020·Veterinary Anaesthesia and Analgesia·Urshulaa DholakiaBruno H Pypendop

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.